Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor

BACKGROUND AND OBJECTIVES: Obesity is a global epidemic which increases the risk of the metabolic syndrome. Cathelicidin (LL-37 and mCRAMP) is an antimicrobial peptide with an unknown role in obesity. We hypothesize that cathelicidin expression correlates with obesity and modulates fat mass and hepa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Obes (Lond)
Main Authors: Tran, Deanna Hoang-Yen, Tran, Diana Hoang-Ngoc, Mattai, S. Anjani, Sallam, Tamer, Ortiz, Christina, Lee, Elaine C., Robbins, Lori, Ho, Samantha, Lee, Jung Eun, Fisseha, Elizabeth, Shieh, Christine, Sideri, Aristea, Shih, David Q, Fleshner, Philip, McGovern, Dermot PB, Vu, Michelle, Hing, Tressia C., Bakirtzi, Kyriaki, Cheng, Michelle, Su, Bowei, Law, Ivy, Karagiannides, Iordanes, Targan, Stephan R., Gallo, Richard L., Li, Zhaoping, Koon, Hon Wai
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5014693/
https://ncbi.nlm.nih.gov/pubmed/27163748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ijo.2016.90
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados